Content uploaded by Emily C Dunford
Author content
All content in this area was uploaded by Emily C Dunford on Oct 23, 2023
Content may be subject to copyright.
Downloaded from http://journals.lww.com/acsm-msse by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/07/2021
Downloadedfromhttp://journals.lww.com/acsm-msse by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/07/2021
. . . Published ahead of Print
Medicine & Science in Sports & Exercise® Published ahead of Print contains articles in unedited
manuscript form that have been peer reviewed and accepted for publication. This manuscript will undergo
copyediting, page composition, and review of the resulting proof before it is published in its final form.
Please note that during the production process errors may be discovered that could affect the content.
Copyright © 2020 American College of Sports Medicine
Both Traditional and Stair Climbing–based HIIT Cardiac Rehabilitation
Induce Beneficial Muscle Adaptations
Changhyun Lim1, Emily C. Dunford1, Sydney E. Valentino1, Sara Y. Oikawa1,
Chris McGlory2, Steve K. Baker3, Maureen J. MacDonald1, Stuart M. Phillips1
1Department of Kinesiology, McMaster University, Hamilton, ON, Canada; 2School
of Kinesiology and Health Studies, Queens University, Kingston, ON, Canada;
3Department of Neurology, Michael G. DeGroote School of Medicine, McMaster
University, Hamilton, ON, Canada
Accepted for Publication: 18 November 2020
ACCEPTED
Both Traditional and Stair Climbing–based HIIT Cardiac Rehabilitation
Induce Beneficial Muscle Adaptations
Changhyun Lim1, Emily C. Dunford1, Sydney E. Valentino1, Sara Y. Oikawa1,
Chris McGlory2, Steve K. Baker3, Maureen J. MacDonald1, Stuart M. Phillips1
1Department of Kinesiology, McMaster University, Hamilton, ON, Canada, 2School
of Kinesiology and Health Studies, Queens University, Kingston, ON, Canada,
3Department of Neurology, Michael G. DeGroote School of Medicine, McMaster University,
Hamilton, ON, Canada
Corresponding author
Dr. Stuart M. Phillips
Professor, Department of Kinesiology, McMaster University,
1280 Main Street West, Hamilton, Ontario, Canada
Tel: +1 (905) 525-9140 ext. 24465
Email: phillis@mcmaster.ca
Medicine & Science in Sports & Exercise, Publish Ahead of Print
DOI: 10.1249/MSS.0000000000002573
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
CL is supported by Basic Science Research Program through the National Research Foundation
of Korea (NRF) funded by the Ministry of Education (NRF-2019R1A6A3A03033939). SMP
thanks the Canada Research Chairs program. ECD was supported by the Canadian Institutes of
Health Research-Institute of Gender and Health grant. MJM and SMP are supported by Natural
Sciences and Engineering Research Council Discovery grant. Conflict of Interest. The authors
have no professional relationships with companies or manufacturers who will benefit from the
results of the present study. The results of the present study do not constitute endorsement by
ACSM. The authors declare that the results of the study are presented clearly, honestly, and without
fabrication, falsification, or inappropriate data manipulation.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Abstract
Purpose: There is a lack of knowledge as to how different exercise-based cardiac rehabilitation
programming affects skeletal muscle adaptations in coronary artery disease (CAD) patients. We
first characterized the skeletal muscle from adults with CAD compared to a group of age- and sex-
matched healthy adults. We then determined the effects of a traditional moderate-intensity
continuous exercise program (TRAD) or a high-intensity interval training program via stair
climbing (STAIR) on skeletal muscle metabolism in CAD. Methods: Sixteen adults (n=16, 61±7
yrs), who had undergone recent treatment for CAD, were randomized to perform (3d/wk) either
TRAD (n=7, 30 min at 60-80% of peak heart rate) or STAIR (n=9, 3x6 flights) for 12 wk. Muscle
biopsies were collected at baseline in both CAD and healthy controls (n=9), and at 4 and 12 weeks
after exercise training in CAD patients undertaking TRAD or STAIR. Results: We found that
CAD had a lower capillary-to-fiber ratio (C/Fi, 35±25%, p=0.06), and capillary-to-fiber perimeter
exchange (CFPE) index (23±29%, p=0.034) in type II fibers compared to healthy controls.
However, 12wk of cardiac rehabilitation with either TRAD or STAIR increased C/Fi (type II,
23±14 %, p<0.001), and CFPE (type I, 10±23 %, p<0.01; type II, 18±22%, p=0.002). Conclusion:
Cardiac rehabilitation via TRAD or STAIR exercise training improved the compromised skeletal
muscle microvascular phenotype observed in CAD patients.
Keywords
Coronary artery disease, stair climbing, high-intensity interval training, skeletal muscle
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Introduction
The global mortality rate resulting from cardiovascular disease (CVD) [including
coronary artery disease (CAD) and chronic heart failure (CHF)] is over 17 million persons
annually (1). Exercise-based cardiac rehabilitation is recommended to improve cardiovascular
function and quality of life, and reduce the risk of secondary CVD events (2). To date, most cardiac
rehabilitation exercise programs are designed for the improvement of cardiovascular function,
however, structural and functional abnormalities of skeletal muscle are also frequently observed
in CHF (3), and lower skeletal muscle mass has been associated with both low aerobic capacity
and increased mortality in CAD (4).
Microvascular circulation is essential for the maintenance of function in skeletal muscle
(5). Increases in blood flow and thereby shear stress promotes to the expression of pro-angiogenic
signals, especially endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor
(VEGF) protein (6). However, in CVD peripheral blood flow and oxygen perfusion is often
reduced due to cardiac dysfunction and poor vasoactive control (7, 8). Previous studies have shown
that patients with CAD and CHF have compromised skeletal muscle blood flow and diffusion of
oxygen (9, 10), lower mitochondrial density with reduced PGC 1α protein expression (11), and
unfavorable muscle fiber type distribution (12). Conversely, other studies have shown no
difference in measures of capillary density, mitochondrial volume and the enzymes related to
oxidative capacity with CHF (13, 14). Thus, there is conflicting evidence as to whether differences
in skeletal muscle phenotype exist between those with CVD and their healthy counterparts.
Critically, beyond CHF patients far less is known about the skeletal muscle characteristics in
individuals with CAD.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Recent studies have reported that enhanced satellite cell activation and expansion are
related to greater skeletal muscle fiber capillarization in healthy young individuals (15), and that
capillarization is closely associated with skeletal muscle mass in older adults (16). To our
knowledge, no study has examined these skeletal muscle characteristics in individuals with CAD
compared to healthy controls. Further, little is known about how differing modes of cardiac-
rehabilitation exercise affect skeletal muscle characteristics in individuals with CAD.
Traditional exercise-based cardiac rehabilitation (TRAD) typically consists of moderate-
intensity aerobic exercise for at least 30 min per day, anywhere from 3-7 days a week (17).
Improvements in peak aerobic capacity as well as increased capillary density and succinate
dehydrogenase activity in skeletal muscle in CAD patients have been reported (10). High-intensity
interval exercise training (HIIT) has been shown to be a feasible and effective alternative to TRAD.
Currie et al. showed that three months and six months of stationary bicycle-based HIIT resulted in
equivalent improvements in cardiovascular function (V
O2peak and flow-mediated dilation) in CAD
patients compared to TRAD (18, 19). In addition, even one bout of HIIT demonstrated marked
improvements in the cardiovascular function highlighting the potency of HIIT as an exercise
stimulus to induce favorable physiological adaptations (20). However, less is known about skeletal
muscle adaptation in individuals with CAD following exercise-based cardiac rehabilitation.
The purpose of this study was twofold. First, we characterized differences in skeletal
muscle between individuals with CAD and age, body mass index (BMI), and sex matched healthy
participants. We hypothesized that, based on previous work in CHF patients, CAD participants
would have deteriorated skeletal muscle characteristics (number of satellite cells and capillary-
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
related factors), and a relative fiber atrophy compared to healthy controls participants. We further
aimed to compare the effects of 12 weeks of TRAD and HIIT deployed as stair climbing exercise
training (STAIR) on skeletal muscle phenotype in individuals with CAD. We hypothesized that
both 12 weeks of TRAD and 12 weeks of STAIR would improve skeletal muscle characteristics
in individuals with CAD and that improvements would be similar between exercise modalities.
Methods
Ethics approval. All participants were informed of the purpose, experimental procedures and the
possible risks of the study before providing written informed consent. This study was approved by
the Hamilton Integrated Research Ethics Board (HIREB#3301) and conformed to the Declaration
of Helsinki. This study was registered as a clinical trial at clinicaltrials.gov (NCT03235674).
Participants reported on as part of this study were part of the larger research project (data reported
separately) examining the effectiveness of STAIR on improving endothelial function measured by
brachial artery flow-mediated dilation (FMD) in CAD patients completing outpatient cardiac
rehabilitation.
Participants. Twenty participants (18M/2F, 61±7 years) with CAD and who have had a history
of previous myocardial infarction, coronary artery bypass graft, and/or percutaneous coronary
intervention, were recruited for this study. A sample size calculation based on the primary outcome
variable of flow-mediated dilation showed that 13 participants per group would be adequate to
detect meaningful differences in that outcome. There was no specific sample size calculation
performed for the skeletal muscle characteristics.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
All participants were non-smokers, had stable medical therapy and had registered to
participate in exercise-based cardiac rehabilitation at the Cardiac Health and Rehabilitation Centre
(CHRC) at the Hamilton General Hospital. Exclusion criteria included any non-cardiac surgical
procedure within two months, symptomatic peripheral arterial disease that limits exercise capacity,
coronary heart failure (NYHA class II-IV confirmed via echocardiography), surgically inserted
pacemakers, atrial fibrillation, documented peak orifice area valve stenosis, any musculoskeletal
abnormality that would limit exercise participation (regular use of a mobility device,
neuromuscular or neurometabolic disease), unstable angina, uncontrolled hypertension (> 180/100
mmHg), and documented chronic obstructive pulmonary disease (FEV1 <60% and/or FVC <60%).
Two participants withdrew from the study due to time constraints. We were unable to collect
adequate muscle biopsy samples from two participants following the baseline biopsy; hence, total
16 participants (16M/1F, 61±7 years) were included in the analysis. In addition, we studied muscle
samples from nine healthy participants from previous trials the muscle from whom served as
controls, and were individually matched (according to age, sex, and BMI) with nine, randomly
selected, participants with CAD.
Study design. This study was a non-blinded, parallel group design. To examine differences in
resting skeletal muscle characteristics between CAD and healthy controls, muscle biopsies were
taken at baseline from the vastus lateralis for the determination of muscle fiber cross-sectional
area, satellite cell content, myonuclear content, capillary-related factors, and expression of proteins
related to vascular and mitochondrial function. Following screening assessments and baseline
measures, CAD participants were randomly assigned via a computer-generated random number
sequence, to participate in 12 weeks [6 supervised exercised sessions over 4 weeks, followed by 8
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
weeks of unsupervised exercise (~24 exercise sessions)] of either TRAD or STAIR. Skeletal
muscle biopsies were taken at 4 weeks (following 6 supervised sessions) and after 8 additional
weeks (unsupervised session) of the exercise interventions in CAD participants only.
Rehabilitation exercise training. All participants performed a medically supervised
cardiopulmonary exercise test (CPET) on either a treadmill or cycle ergometer for the
measurement of peak cardiorespiratory fitness (V
O2peak), and peak heart rate (HRpeak) using
metabolic cart (Sensor Medics Vmax 229; California, USA) ahead of enrollment at the CHRC.
For the cycle ergometer, the workload was increased by 100 KPM per minute. For the treadmill,
the test was conducted in accordance with the Bruce protocol. The treadmill workload started at
2.0 mph with 0% grade and after one-minute, only the speed increased to 3.0 mph. Each minute
following, the incline increased by 2.5% grade. Once the grade reached 20%, the speed was
increased by 0.5mph per minute.
The TRAD training consisted of 30 min of moderate-intensity continuous exercise on
combination of stationary cycling, treadmill and/or self-paced walking The exercise intensity for
the TRAD group was determined using a target training heart rate from individual CPET results
through the heart rate-reserve (HRR) method. Exercise was completed at 60-80% HRRs with an
intensity goal of 11-13 on Borg’s Rate of Perceived Exertion (RPE) 6-20 scale. STAIR exercise
sessions consisted of 3 bouts of ascending and descending of single flight of stairs (12 steps) six
times at a self-selected vigorous intensity. Individuals in STAIR were asked to climb up and down
the stairs one step at a time and ascend at a pace that challenged them (RPE 14-15/20) and to
descend at a pace that was comfortable. Between each bout of stair climbing, participants
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
performed 90 seconds of active recovery consisting of light walking on flat ground. Continuous
heart rate was monitored by a chest worn heart rate monitor (Polar A300, Polar H9 heart rate sensor,
Polar Electro Oy, Finland) to assess exercise intensity. Both TRAD and STAIR sessions began
with a 10 min warm-up and finished with a 5 min cool down consisting of light walking. To ensure
the use of proper technique, all participants performed 6 exercise sessions of their assigned
exercise modality at CHRC under the supervision of a certified healthcare professional for the first
4 weeks. For the subsequent 8 weeks, both groups were asked to continue to perform their exercise
program, unsupervised 3 days per week at home or in a community-based exercise facility.
Participants continued to use heart rate monitoring during at home exercise sessions and these data
were available to study investigators after upload by the participants.
Muscle biopsy procedure. All muscle biopsies were collected following an overnight fast (>10
hours) and were taken at baseline, and after 4 and 12 weeks of exercise training in CAD
participants, and at baseline only in healthy controls. Participants were advised to refrain from
exercise and alcohol consumption for 24 hours and caffeine consumption for 10 hours prior to
muscle biopsy sampling. All prescribed medications and vitamins were taken as usual, except for
any vasoactive medications (i.e., nitroglycerin). All muscle biopsies were obtained with the use of
a 5-mm Bergström needle that was adapted for manual suction under 1% xylocaine local
anesthesia. Muscle tissue was then carefully freed from visible connective tissue, fat, and blood
through manual dissection. A piece of the muscle tissue was embedded in optical cutting
temperature compound (OCT; Tissue-Tek, The Netherlands) for histochemical analysis and OCT
embedded tissue and whole muscle were both rapidly frozen in liquid nitrogen and stored at -80°C
for further analysis.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Immunohistochemistry. Muscle tissue embedded in OCT was cut on a cryostat (5㎛) maintained
at a temperature of -20°C and transferred to a positively charged glass slide. After fixation in a 4%
paraformaldehyde (PFA) solution for 5 min, the slides were submerged in methanol and stored at
-20°C for 10 min to remove fat. After placement in a blocking solution (goat serum and 0.1%
triton/PBS at a 9:1 ratio) for 20 min, the slides were incubated with primary antibodies against
Pax7 (MAB 1675, 1:100, R&D system, Minneapolis, MN, USA), myosin heavy chain type I
(MHC I, A4.951, 1:1, Developmental Studies Hybridoma Bank, Iowa City, USA), myosin heavy
chain type II (MHC II, ab91506, 1:1000, Abcam, Cambridge, MA, USA), laminin (ab11575, 1:500,
Abcam, Cambridge, MA, USA), and CD31 (ab28364, 1:20, Abcam, Cambridge, MA, USA).
Secondary antibodies used for Pax 7 were (Alexa Fluor 594, 1:500, Thermo Fisher Scientific,
Waltham, MA, USA); MHC I (Alexa Fluor 488 or 594, 1:500, Thermo Fisher Scientific, Waltham,
MA, USA); MHC II (Alexa Fluor 647 or 350, 1:500, Thermo Fisher Scientific, Waltham, MA,
USA); laminin (Alexa Flour 488 or 350, 1:500, Thermo Fisher Scientific, Waltham, MA, USA);
CD31 (Alexa Flour 488, 1:500, Thermo Fisher Scientific, Waltham, MA, USA). Nuclei were
stained with 4,6-diamidino-2-phenylindole (DAPI, 1:20000, Sigma-Aldrich, Oakville, ON,
Canada). Lastly, the slides were mounted with Prolong Diamond Antifade Reagent (Life
Technologies, Burlington, ON, Canada). All analysis was completed with the investigator blinded
to group and time point.
Samples were imaged by Nikon Eclipse 90i microscope equipped with high-resolution
Photometrics CoolSNAP HQ2 fluorescence camera (Nikon Instruments, Melville, NY, USA). All
images were obtained with x 20 objective and analyzed using Nikon NIS element AR software
(Nikon Instruments). To ensure the reliability of cross sectional analysis (CSA), muscle fiber type,
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
satellite cell content, and myonuclear content, ~200 muscle fibers per sample were analyzed (21).
Additionally, 50 muscle fibers per sample were analyzed for quantification of the capillary-to fiber
ratio on an individual fiber basis (C/Fi), and the capillary-to-fiber perimeter exchange index (CFPE)
for the measurement of capillary-to-fiber surface area (22).
Western blotting. To analyze protein expression and phosphorylation, snap-frozen muscle tissue
was homogenized with ice-cold lysis buffer [10μL/mg; 25mM Tris 0.5% vol: vol Triton X-100
and protease/phosphatase inhibitor cocktail tablets (Complete Protease inhibitor Mini-Tabs, Roche;
and PhosSTOP, Roche Applied Science)] and centrifuged at 1,500 g for 10 min at 4°C. The protein
concentration of the supernatant (sarcoplasmic fraction) was determined via bicinchoninic acid
assay (Thermo Scientific, Waltham, MA, USA). 4X Laemmli buffer (0.25 M Tris, 4% SDS, 20%
glycerol, 0.015% bromophenol blue and 10% 2-mercaptoethanol) was added to working samples
and equal amounts of protein (10 ㎍) from each sample were loaded into wells on 4-15% TGX
Stain-Free Precast Gels (Bio-Rad, Hercules, CA, USA). A protein ladder (Precision Plus Protein
Standard, Bio-Rad, Hercules, CA, USA) and 4 internal standard calibration curves were loaded on
every gel. Gel electrophoresis was run at 200 volts for 45 min. The protein transfer from the gel to
a nitrocellulose membrane was carried out by turbo transfer (#1704150, Bio-Rad, Hercules, CA,
USA). To ensure a complete protein transfer, membrane pre- and post-transfer images were
checked using the ChemiDoc MP Imaging System (#12003154, Bio-Rad, Hercules, CA, USA).
Membranes were then blocked with 5% bovine serum albumin (BSA) for 90 min at room
temperature. The primary antibodies, total endothelial nitric oxide synthase (eNOS, 9572, 1:1000,
Cell signaling, Danvers, MA, USA), phospho-eNOSSer1177 (9571S, 1:1000, Cell signaling, Danvers,
MA, USA), vascular endothelial growth factor (VEGF, ab46154, 1:1000, Abcam Cambridge, MA,
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
USA), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1-alpha,
Ab3242, 1:1000, Merck Millipore, Billerica, MA, USA), cytochrome c oxidase subunit IV (COX
IV, Ab110261, 1:1000, Abcam, Cambridge, MA, USA) were incubated in a blocking solution for
12 hours at 4°C. The membranes were then washed 3 x 5 min with tris-buffered saline and Tween
20 (TBS-T, Millipore Sigma, Oakville, ON, Canada), and incubated with the appropriate host
species secondary antibody for 90 min at room temperature. The secondary antibodies were
removed by 3 x 5 min washing with TBS-T. Membrane bands were detected by
chemiluminescence solution (Clarity Western ECL substrate, Bio-Rad, Hercules, CA, USA) and
images were scanned using the ChemiDoc MP Imaging system, and analyzed by Image Lab
Software for PC version 6.0.1.
Statistical analysis. The distribution of data was assessed using the Shapiro-Wilk test. All non-
normally distributed data are specified in the figure legend. Characteristics of CAD and healthy
control participants, and TRAD vs. STAIR participants at baseline, were analyzed with an
independent sample t-test, for normally distributed data, or a Mann-Whitney test for non-normally
distributed data. Two-way repeated measures analysis of variance (ANOVA) was used to compare
TRAD and STAIR with the exercise intervention as the between-subjects variable and time
(Baseline, 4 weeks and 12 weeks) as the within-subjects variable. All significant interactions from
the ANOVA analysis were further examined via Tukey’s post hoc test. Differences in non-normal
distributed data in this comparison were analyzed with robust two-way between-within ANOVA
in R. Trimmed means were used as a measure of location rather than the mean, which is subject to
outlier effects, with the trimming parameter set to 0.2. Hochberg-adjusted multiple comparisons
for interaction and main effects were conducted using the ‘bwmcppb.adj’ function to control for
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
familywise error, as described in Wilcox (23). Statistical significance was set at p < 0.05. Data are
presented as means±SD or graphed as means with individual data and showing the 95% confidence
interval (CI). Statistical analyses were completed using the SPSS Statistics software package
(SPSS Statistics, Version 26.0 for Windows, IBM Corp., Armonk, NY, USA) or R (version 4.0.2).
Results
Participant Characteristics. Baseline characteristics of the participants are presented in Table 1.
There were no differences in anthropometric measures between CAD and healthy controls
(p>0.05), or between TRAD and STAIR (p>0.05). There were no differences in clinical outcomes,
aerobic fitness (V
O2peak), CVD risk factors (type 2 diabetes, hypertension, dyslipidemia), blood
variables (fasted glucose, fasted insulin, high-density lipoprotein, low-density lipoprotein,
Triglycerides, cholesterol), or medication between TRAD and STAIR (p>0.05).
Characteristics of cardiac rehabilitation exercise. Participants in both the TRAD (3.0±2.2
d/week) and STAIR (3.0±3.2 d/week) groups adhered to their respective exercise programs
throughout the 12 weeks intervention. During exercise, STAIR elicited a greater HRpeak compared
to TRAD (112±14 vs 129±11 bpm, p=0.008). In addition, the average %HRpeak was 12% higher
in STAIR compared to TRAD (p=0.028). The average total exercise time per session at the
prescribed intensity of STAIR was significantly shorter compared to TRAD (STAIR: 5±2 min
versus TRAD: 33±8 min, p<0.001). Exercise protocol values following 12 weeks of exercise
training are presented in Supplemental Digital Content 1, http://links.lww.com/MSS/C212.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Skeletal muscle phenotype in CAD and healthy controls. Participants with CAD had a 52±88%
lower prevalence of type I fibers (p=0.034) and 14±21% higher percentage of type II fibers
(p=0.034) (Figure 1A). There were no differences in fiber CSA for type I or II fibers between CAD
and healthy controls (type I fibers: p=0.141, type II fibers: p=0.084, Figure 2B). There was no
difference in satellite cell (p=0.282) or myocnulei content per fiber in type II fibers between CAD
and healthy controls (p=0.094), however, type I muscle fiber-associated satellite cell and
myonuclei content per fiber were 181±354% (p=0.019) and 24±22% (p=0.017) lower in CAD
compared to healthy controls respectively (Figure 1C and D). There were no differences in C/Fi
number (p=0.063) or CFPE index (p=0.123) in type I fibers between CAD and healthy controls.
However, type II fiber C/Fi number and CFPE index were 35±25% (p=0.06) and 23±29% (p=0.034)
lower in CAD compared to healthy controls respectively (Figure 1E and F).
Capillary and mitochondria-related protein expression between CAD and healthy controls.
There was no difference in the ratio of phosphorylation to total eNOSSer1177 (p=0.24) or COX IV
(p=0.44) protein expression between CAD and healthy controls (Figure 2A and D). PCG 1α and
VEGF protein expression in CAD was 128±149% (p=0.024) and 120±173% (p=0.044),
respectively lower compared to healthy controls (Figure 2B and C).
Changes in skeletal muscle phenotype with exercise training in CAD patients. There were no
changes in fiber CSA during the exercise training interventions (type I fibers: p=0.39, type II fibers:
p=0.911) and no differences between CAD groups (type I fibers: p=0.67, type II fibers: p=0.638)
at any time point (Figures 3A and B). Satellite cell content per fiber in type I fibers increased at 4
weeks (22±56%, p=0.011) with no difference between training groups (p=0.076). Satellite cell
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
content per fiber in type I fibers returned to those similar to baseline at 12 weeks (p=0.284, Figure
3C). Satellite cell content per fiber in type II fibers was greater at 12 weeks of training compared
to baseline (35±35%, p=0.046) and at 4 weeks (25±33%, p=0.003) in STAIR only (Figure 3D).
There was no difference in the number of myonuclei per fiber at 4 weeks (type I fibers: p=0.406,
type II fibers: p=0.05); however, myonuclei number per fiber increased by 8±15% in type I fibers
(p=0.012) and 12±19% in type II fibers (p=0.006) following 12 weeks of training with no
differences between groups (type I fibers: p=0.359, type II fibers: p=0.952) (Figure 3E and F).
Capillarization with exercise training in CAD patients. There was no difference in C/Fi number
in type I fibers following TRAD or STAIR training at any timepoint (p>0.05, Figure 4A). C/Fi in
type II fibers increased by 17±12at 4 weeks (p<0.001) and by 23±14 at 12 weeks (p<0.001) with
no difference between groups (p=0.30) (Figure 4B). CFPE index in type I fibers increased by
11±14% at 4 weeks (p<0.01) and by 10±23% at 12 weeks (p<0.01) with no difference between
groups (p=0.066) (Figure 4C). CFPE index increased 18±14% at 4 weeks (p<0.001) and 18±22%
at 12 weeks (p=0.002) in type II fibers with no difference between groups (p=0.17) (Figure 4D).
Capillary and mitochondria-related protein expression with exercise training in CAD
patients. There was a significant increase in the ratio of phosphorylation to total eNOSSer1177 at 4
weeks of training by 19±33% (p<0.01) with no difference between groups (p=0.127). This ratio
was not change from baseline at 12 weeks (p=0.073, Figure 5A). There was no difference in VEGF
protein expression at 4 weeks or 12 weeks (p>0.05, Figure 5B). Protein expression of PGC 1α
increased by 19±52% at 4 weeks (p=0.046) and 23±41% at 12 weeks (p=0.014) with no differences
between groups (p=0.11) (Figure 5C). There was a main effect for time in protein expression of
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
COX IV (p=0.048). However, there was no significant post-hoc effect when p-values are adjusted
for multiple comparisons (Figure 5D).
Discussion
We discovered marked differences in skeletal muscle characteristics in CAD patients compared to
age, sex, and BMI-matched healthy older adults as evidenced by a lower percentage of type I fibers,
a decreased number of satellite cells, and decreased number of myonuclei per fiber in type I fibers.
Additionally, skeletal muscle from CAD patients exhibited significantly reduced capillary-related
indices C/Fi and CFPE in type II fibers, as well as lower VEGF and PGC1α protein expression
compared to controls. We are uncertain whether these findings are a determinant or consequence
of CAD, but they highlight that CAD patients have a lower skeletal muscle metabolic quality and
display a pre-sarcopenic skeletal muscle phenotype (24). Critically, we show for the first time, to
our knowledge, that despite reduced satellite cell and myonuclear content, and lower capillary-
related factors compared to healthy controls, individuals with CAD are able to ameliorate these
decrements with 12 weeks of either TRAD or STAIR exercise training. Additionally, despite a 6-
fold shorter average exercise time required by STAIR (~5±2 min) versus TRAD (~33±8 min), we
observed comparable changes in skeletal muscle phenotype with training. Interestingly, we did
observe increased satellite cell proliferation in type II fibers to a greater extent following the
STAIR program, which is deserving of follow-up.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Skeletal muscle characteristics in individuals with CAD
In general, aging results in the atrophy of type II fibers along with a reduction in the
number of satellite cells and myonuclei per fiber (25). We could not detect differences in the
number of type II fiber satellite cells and myonuclei per fiber between CAD and healthy
participants; however, CAD participants exhibited a lower number of satellite cells and myonuclei
in type I fibers compared to healthy participants. Satellite cells play a vital role in skeletal muscle
repair, remodeling, and growth (26). In aging muscle, declines in satellite cell content are
associated with type II fiber atrophy, which includes loss of muscle mass as well as a loss of the
total number of muscle fibers due to denervation (27). We note that CHF patients have
compromised mitochondrial and capillary-related phenotypes but we could not find an
investigation examining satellite cell characteristics in CHF or CAD patients (28); hence, our data
in CAD patients are a first and without an easy CVD-related comparison. Therefore, while the
profile of type II fibers in CAD was in line with what would be expected with a natural sarcopenic
decline (Figure 1), the presence of CAD is associated with a type I fiber-specific deterioration in
aging skeletal muscle (Figure 1).
Muscle perfusion can have substantial impacts on substrate delivery and many cellular
processes such as protein turnover (5) and oxygen delivery (29). We observed that C/Fi and CFPE
in type II fibers in CAD were lower compared to healthy controls. Additionally, VEGF, an
angiogenic growth factor, showed significantly lower protein expression in CAD participants
compared to healthy controls, findings that are line with the observed reduction in C/Fi in CAD;
however, there was no difference in eNOS protein expression between CAD patients and healthy
controls (Figure 2A and B). We also found that type II fibers in the skeletal muscle of CAD
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
participants had a lower CFPE index compared with healthy controls. Hepple et al., reported a
positive correlation between V
O2peak and CFPE index (30) which supports the notion that impaired
oxygen delivery to skeletal muscle in CAD patients may be due to reduced capillarization in their
skeletal muscle. Previous studies have reported increases in the ubiquitin-proteasome system
through increases in ubiquitin ligases, MuRF1 and MAFbx in CHF patients (31), and decreased
mitochondria content by reduced PGC 1α protein expression in CVD (11). In the present study,
besides PGC 1α protein expression which was lower in CAD, there were no differences in the
CSA of type I or II fibers or differences in the protein expression of COX IV in CAD participants
compared to healthy controls. Further studies are required to fully elucidate the mechanisms
resulting in altered skeletal muscle phenotypes in CAD patients.
Cardiac rehabilitation and skeletal muscle adaptation in CAD patients
To our knowledge, there are very few studies examining the impact of cardiac
rehabilitation on skeletal muscle metabolism in individuals with CAD (4, 10), with no study that
has investigated the effects on skeletal muscle fiber type adaptations. Following 12 weeks of
training, there were no differences in the CSA of type I or II fibers in either group; however, 4
weeks of both TRAD and STAIR was associated with an increase in the number of satellite cells
in type I fibers. Satellite cells are robustly activated in earlier phases of exercise training an effect
that may not be due to muscle damage but may be a normal part of phenotypic adaptation (32).
While there were no differences in the change in satellite cell number in type I fibers between
groups, 12 weeks of STAIR increased satellite cell content in type II fibers to a greater extent
compared to TRAD. Previous studies indicated that HIIT may induce a greater increase in satellite
cell content, particularly in type II fibers versus moderate-intensity endurance exercise (33, 34). In
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
line with these observations, the higher intensity nature of STAIR may have increased the
recruitment of type II fibers in comparison to TRAD, resulting in the greater satellite cell content
in type II fibers at the 12 week timepoint (35). Satellite cell-mediated myonuclear accretion is a
hallmark of largely with skeletal muscle hypertrophy when the upper limits of the myonuclear
domain are reached (36). However, previous studies have shown that satellite cell-mediated
myonuclear accretion can occur with non-hypertrophic stimuli, including endurance exercise, and
may contribute to remodeling of muscle fibers (32).
Both endurance exercise (37) and resistance exercise (38) can promote the expression of
angiogenesis-related signals by including an increase in blood flow and thereby shear stress (6).
Indeed, Tan et al. reported that 6 weeks of HIIT using a cycle ergometer increased capillary
contacts (CC) in type I and II fibers in overweight women (39), and Cocks et al. also reported
increased muscle microvascular eNOS content and capillarization following 6 weeks sprint
interval training and traditional endurance training (40). We report that 4 weeks of both TRAD
and STAIR increased C/Fi in type II fibers in CAD participants and that increase was maintained
at 12 weeks of training in both groups. This finding is paralleled by the observed increase in
maximal V
O2peak following training [Dunford and MacDonald, personal communication]. As
increased capillary density is not only closely connected to the delivery of oxygen and nutrients
but also enhances activation and expansion of satellite cell content for skeletal muscle repair (15);
thus, the increased capillary density following TRAD and STAIR may allow for regeneration and
repair of comprised skeletal muscle in CAD. Indeed, individuals who have a lower capillarization
in skeletal muscle at baseline showed the lower extent of skeletal muscle mass increase following
resistance exercise in older men (16), and 12 months of longer exercise-based traditional cardiac
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
rehabilitation increased individual fiber area accompanied with increased capillary density in CAD
patients (10). While Tan et al. reported the increase in CC for both type I and II fibers following
HIIT (39), we observed the increase in C/Fi in type II fibers only. The disparate findings may be
due to the characteristics of different participants performing the exercise training.
Secretion of VEGF protein during exercise plays critical roles in promoting angiogenesis
by stimulating endothelial cells to proliferate, migrate, and differentiate (41). In addition, VEGF
upregulates the expression of eNOS, which synthesizes endothelial nitric oxide (NO) (42). The
release of endothelial NO induces vasodilation and thereby improves blood flow and perfusion
(43). We observed no further increase in C/Fi at 12 weeks of both TRAD and STAIR from 4 weeks
(Figure 4). In line with our observations, 4 weeks of both TRAD and STAIR increased
phosphorylation of eNOS but these values returned to those similar to baseline at 12 weeks.
However, there were no changes in VEGF protein expression in either group following exercise
training despite an increased C/Fi. An increase in VEGF protein expression following exercise is
transient, with levels returning to baseline within 2 hours after exercise cessation (44). Given that
muscle biopsies were collected at rest and participants were required to refrain from physical
activity 24 hours prior to muscle biopsy sampling, the lack of augmented VEGF is perhaps not
surprising.
Individuals with CHF had reduced oxidative capacity of skeletal muscle indicative of
lower mitochondria density (9). Here we show that both TRAD and STAIR increased expression
of the PGC 1α after 4 and 12 weeks, whereas there was no difference in protein expression of COX
IV following either exercise training program (45). Six sessions of HIIT over 2 weeks led to the
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
increase in mitochondria content measured by citrate synthase (CS) activity and respiration in
young men (46). In addition, 6 weeks of HIIT increased mitochondrial content in older men and
women (47). Given that the former study, while the 2 weeks of HIIT training duration was possible
to induce mitochondrial biogenesis in young adults, CAD patients who have relatively
compromised skeletal muscle characteristics may need a longer period of training to lead to
mitochondrial biogenesis even though the expression of PGC 1α was increased at 4 and 12 weeks
of training. Mitochondrial volume and content have been correlated with V
O2peak (48), which is a
strong predictor of mortality (49), and CAD patients generally have a lower oxygen consumption
capacity. Thus, exercise training following a cardiac event should be considered as a means to
improve muscle oxidative capacity in CAD individuals.
Our novel findings highlight that while CAD patients have compromised skeletal muscle
function compared with healthy controls, that both TRAD, and a practical and time-efficient
alternative, STAIR, are equally effective in improving skeletal muscle metabolic characteristics
following a cardiac event. However, we recognize that our small sample size is a limitation as this
would inflate the risk of a type II statistical error. Also, 8 weeks of the training was unsupervised,
so we were not able to control the exact exercise intensity performed by participants and had to
rely on self-report and heart rate monitoring results for adherence estimates and confirmation.
In conclusion, we show that CAD is associated with smaller muscle fibers, reductions in
satellite cell and myonuclei number, and capillary-related perfusion capacity of skeletal muscle in
comparison to healthy controls. Critically, we found that 4 and 12 weeks of cardiac rehabilitation
in the form of either TRAD or STAIR improved these compromised skeletal muscle characteristics
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
by increasing the number of satellite cells, myonuceli, and capillary-related factors induced by
CAD. We conclude that skeletal muscle metabolism in individuals with CAD can be improved
with exercise-based cardiac rehabilitation. Also, HIIT-based stair climbing, which is easily
accessible, could be a feasible and practical alternative to traditional cardiac rehabilitation exercise,
despite shorter average exercise time.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Acknowledgments
CL is supported by Basic Science Research Program through the National Research Foundation
of Korea (NRF) funded by the Ministry of Education (NRF-2019R1A6A3A03033939). SMP
thanks the Canada Research Chairs program. ECD was supported by the Canadian Institutes of
Health Research-Institute of Gender and Health grant. MJM and SMP are supported by Natural
Sciences and Engineering Research Council Discovery grant.
Conflict of Interest
The authors have no professional relationships with companies or manufacturers who will benefit
from the results of the present study. The results of the present study do not constitute endorsement
by ACSM. The authors declare that the results of the study are presented clearly, honestly, and
without fabrication, falsification, or inappropriate data manipulation.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
References
1. Moodie DS. The Global Burden of Cardiovascular Disease. Congenit Heart Dis.
2016;11(3):213.
2. Belardinelli R, Georgiou D, Cianci G, Purcaro A. 10-year exercise training in chronic heart
failure: a randomized controlled trial. J Am Coll Cardiol. 2012;60(16):1521-8.
3. Adams V, Doring C, Schuler G. Impact of physical exercise on alterations in the skeletal
muscle in patients with chronic heart failure. Front Biosci. 2008;13:302-11.
4. Nichols S, O'Doherty AF, Taylor C, Clark AL, Carroll S, Ingle L. Low skeletal muscle mass
is associated with low aerobic capacity and increased mortality risk in patients with
coronary heart disease - a CARE CR study. Clin Physiol Funct Imaging. 2019;39(1):93-
102.
5. Timmerman KL, Lee JL, Dreyer HC et al. Insulin stimulates human skeletal muscle protein
synthesis via an indirect mechanism involving endothelial-dependent vasodilation and
mammalian target of rapamycin complex 1 signaling. J Clin Endocrinol Metab.
2010;95(8):3848-57.
6. Brown MD, Hudlicka O. Modulation of physiological angiogenesis in skeletal muscle by
mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis.
2003;6(1):1-14.
7. Coats AJ. The "muscle hypothesis" of chronic heart failure. J Mol Cell Cardiol.
1996;28(11):2255-62.
8. Rogers FJ. The muscle hypothesis: a model of chronic heart failure appropriate for
osteopathic medicine. J Am Osteopath Assoc. 2001;101(10):576-83.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
9. Esposito F, Mathieu-Costello O, Shabetai R, Wagner PD, Richardson RS. Limited maximal
exercise capacity in patients with chronic heart failure: partitioning the contributors. J Am
Coll Cardiol. 2010;55(18):1945-54.
10. Ades PA, Waldmann ML, Meyer WL et al. Skeletal muscle and cardiovascular adaptations
to exercise conditioning in older coronary patients. Circulation. 1996;94(3):323-30.
11. Rosca MG, Hoppel CL. Mitochondrial dysfunction in heart failure. Heart Fail Rev.
2013;18(5):607-22.
12. Magnusson G, Kaijser L, Rong H, Isberg B, Sylven C, Saltin B. Exercise capacity in heart
failure patients: relative importance of heart and skeletal muscle. Clin Physiol.
1996;16(2):183-95.
13. Toth MJ, Miller MS, Ward KA, Ades PA. Skeletal muscle mitochondrial density, gene
expression, and enzyme activities in human heart failure: minimal effects of the disease
and resistance training. J Appl Physiol (1985). 2012;112(11):1864-74.
14. Williams AD, Selig S, Hare DL et al. Reduced exercise tolerance in CHF may be related
to factors other than impaired skeletal muscle oxidative capacity. J Card Fail.
2004;10(2):141-8.
15. Nederveen JP, Joanisse S, Snijders T, Thomas ACQ, Kumbhare D, Parise G. The influence
of capillarization on satellite cell pool expansion and activation following exercise-induced
muscle damage in healthy young men. J Physiol. 2018;596(6):1063-78.
16. Snijders T, Nederveen JP, Joanisse S et al. Muscle fibre capillarization is a critical factor in
muscle fibre hypertrophy during resistance exercise training in older men. J Cachexia
Sarcopenia Muscle. 2017;8(2):267-76.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
17. Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV. Exercise training and cardiac
rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin
Proc. 2009;84(4):373-83.
18. Currie KD, Dubberley JB, McKelvie RS, MacDonald MJ. Low-volume, high-intensity
interval training in patients with CAD. Med Sci Sports Exerc. 2013;45(8):1436-42.
19. Currie KD, Bailey KJ, Jung ME, McKelvie RS, MacDonald MJ. Effects of resistance
training combined with moderate-intensity endurance or low-volume high-intensity
interval exercise on cardiovascular risk factors in patients with coronary artery disease. J
Sci Med Sport. 2015;18(6):637-42.
20. Currie KD, McKelvie RS, Macdonald MJ. Flow-mediated dilation is acutely improved
after high-intensity interval exercise. Med Sci Sports Exerc. 2012;44(11):2057-64.
21. Mackey AL, Kjaer M, Charifi N et al. Assessment of satellite cell number and activity
status in human skeletal muscle biopsies. Muscle Nerve. 2009;40(3):455-65.
22. Hepple RT, Mackinnon SL, Thomas SG, Goodman JM, Plyley MJ. Quantitating the
capillary supply and the response to resistance training in older men. Pflugers Arch.
1997;433(3):238-44.
23. Wilcox R. Introduction to Robust Estimation and Hypothesis Testing 4th Edition.
ELSEVIER; 2017, 810 p.
24. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition
and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age
Ageing. 2010;39(4):412-23.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
25. Verdijk LB, Snijders T, Drost M, Delhaas T, Kadi F, van Loon LJ. Satellite cells in human
skeletal muscle; from birth to old age. Age (Dordr). 2014;36(2):545-7.
26. Sambasivan R, Yao R, Kissenpfennig A et al. Pax7-expressing satellite cells are
indispensable for adult skeletal muscle regeneration. Development. 2011;138(17):3647-56.
27. Snijders T, Nederveen JP, McKay BR et al. Satellite cells in human skeletal muscle
plasticity. Front Physiol. 2015;6:283.
28. Niemeijer VM, Snijders T, Verdijk LB et al. Skeletal muscle fiber characteristics in patients
with chronic heart failure: impact of disease severity and relation with muscle oxygenation
during exercise. J Appl Physiol (1985). 2018;125:1266-76.
29. Radegran G, Blomstrand E, Saltin B. Peak muscle perfusion and oxygen uptake in humans:
importance of precise estimates of muscle mass. J Appl Physiol (1985). 1999;87(6):2375-
80.
30. Hepple RT, Mackinnon SL, Goodman JM, Thomas SG, Plyley MJ. Resistance and aerobic
training in older men: effects on VO2peak and the capillary supply to skeletal muscle. J
Appl Physiol (1985). 1997;82(4):1305-10.
31. Mangner N, Weikert B, Bowen TS et al. Skeletal muscle alterations in chronic heart failure:
differential effects on quadriceps and diaphragm. J Cachexia Sarcopenia Muscle.
2015;6(4):381-90.
32. Joanisse S, Gillen JB, Bellamy LM et al. Evidence for the contribution of muscle stem cells
to nonhypertrophic skeletal muscle remodeling in humans. FASEB J. 2013;27(11):4596-
605.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
33. Charifi N, Kadi F, Feasson L, Denis C. Effects of endurance training on satellite cell
frequency in skeletal muscle of old men. Muscle Nerve. 2003;28(1):87-92.
34. Verney J, Kadi F, Charifi N et al. Effects of combined lower body endurance and upper
body resistance training on the satellite cell pool in elderly subjects. Muscle Nerve.
2008;38(3):1147-54.
35. Godin R, Ascah A, Daussin FN. Intensity-dependent activation of intracellular signalling
pathways in skeletal muscle: role of fibre type recruitment during exercise. J Physiol.
2010;588(Pt 21):4073-4.
36. Van der Meer SF, Jaspers RT, Degens H. Is the myonuclear domain size fixed? J
Musculoskelet Neuronal Interact. 2011;11(4):286-97.
37. Richardson RS, Wagner H, Mudaliar SR, Saucedo E, Henry R, Wagner PD. Exercise
adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart
Circ Physiol. 2000;279(2):H772-8.
38. Gavin TP, Drew JL, Kubik CJ, Pofahl WE, Hickner RC. Acute resistance exercise increases
skeletal muscle angiogenic growth factor expression. Acta Physiol (Oxf). 2007;191(2):139-
46.
39. Tan R, Nederveen JP, Gillen JB et al. Skeletal muscle fiber-type-specific changes in
markers of capillary and mitochondrial content after low-volume interval training in
overweight women. Physiol Rep. 2018;6(5).
40. Cocks M, Shaw CS, Shepherd SO et al. Sprint interval and endurance training are equally
effective in increasing muscle microvascular density and eNOS content in sedentary males.
J Physiol. 2013;591(3):641-56.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
41. Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN. Control of endothelial cell
proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad
Sci U S A. 2008;105(22):7738-43.
42. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein,
and NO production in human endothelial cells. Am J Physiol. 1998;274(3):H1054-8.
43. Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J
Am Coll Cardiol. 1996;28(7):1652-60.
44. Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, Hickner RC. Angiogenic
growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol
(1985). 2004;96(1):19-24.
45. Larsen S, Nielsen J, Hansen CN et al. Biomarkers of mitochondrial content in skeletal
muscle of healthy young human subjects. J Physiol. 2012;590(14):3349-60.
46. MacInnis MJ, Zacharewicz E, Martin BJ et al. Superior mitochondrial adaptations in
human skeletal muscle after interval compared to continuous single-leg cycling matched
for total work. J Physiol. 2017;595(9):2955-68.
47. Chrois KM, Dohlmann TL, Sogaard D et al. Mitochondrial adaptations to high intensity
interval training in older females and males. Eur J Sport Sci. 2020;20(1):135-45.
48. van der Zwaard S, de Ruiter CJ, Noordhof DA et al. Maximal oxygen uptake is proportional
to muscle fiber oxidative capacity, from chronic heart failure patients to professional
cyclists. J Appl Physiol (1985). 2016;121(3):636-45.
49. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and
mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793-801.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Figure legends
Figure 1. Skeletal muscle characteristics in CAD patients and healthy controls. The ratio of
the fiber type composition to type I and type II (A) and the cross-sectional area (B). The number
of Pax7+ satellite cells (C) and myonuclei (D) per fiber. Individual muscle fiber capillary-to-fiber
ratio (C/Fi) (E) and capillary-to-fiber perimeter exchange (CFPE) per 1000㎛ of cross-sectional
area (F). CAD: coronary artery disease, white bars represent healthy controls, grey bars represent
CAD, Data are expressed as means and 95% CI±SD. *p<0.05, significantly different from healthy
controls within each fiber type.
Figure 2. Expression of capillary and mitochondria-related proteins. The ratio of
phosphorylation to total endothelial nitric oxide synthase (eNOS)Ser1177 (A), vascular endothelial
growth factor (VEGF) (B), peroxisome proliferator-activated receptor-gamma coactivator 1α
(PGC 1α) (C; Mann-Whitney test), and cytochrome c oxidase subunit IV (COX IV) (D; Mann-
Whitney test), representative western blotting bands (E). AU: arbitrary unit, HC: healthy controls,
CAD: coronary artery disease, white bars represent TRAD, grey bars represent STAIR. Data are
expressed as means and 95% CI. *p<0.05, significantly different from healthy controls.
Figure 3. Changes in skeletal muscle characteristics at 4 and 12 weeks following TRAD and
STAIR training in CAD patients. Skeletal muscle CSA for type I (A; Robust ANOVA) and type
II (B). The number of Pax7+ satellite cells per fiber for type I (C) and type II (D). The number of
myonuclei per fiber for type I (E) and type II (F). CSA: cross-sectional area, BL: baseline, 4w: 4
weeks, 12w: 12 weeks, TRAD: traditional moderate-intensity continuous exercise program,
STAIR: stair climbing based high-intensity interval exercise program, white bars represent TRAD,
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
grey bars represent STAIR, Data are expressed as means and 95% CI. *p<0.05, significantly
different from BL within group, # p<0.05, significantly different from 4w within group, † p<0.05
significantly different from BL.
Figure 4. Changes in capillarization at 4 and 12 weeks following TRAD and STAIR training
in CAD patients. Individual muscle fiber capillary-to fiber ratio (C/Fi) for type I (A) and type II
(B; Robust ANOVA). Capillary to fiber perimeter exchange (CFPE) per 1000㎛ for type I (C;
Robust ANOVA) and type II (D). BL: baseline, 4w: 4 weeks, 12w: 12 weeks, TRAD: traditional
moderate-intensity continuous exercise program, STAIR: stair climbing based high-intensity
interval exercise program, white bars represent TRAD, grey bars represent STAIR. Data are
expressed as means and 95% CI. † p<0.05, significantly different from BL.
Figure 5. Changes in expression of capillary and mitochondria-related proteins at 4 and 12
weeks following TRAD and STAIR training in CAD patients. The ratio of phosphorylation to
total endothelial nitric oxide synthase (eNOS)Ser1177 (A; Robust ANOVA), vascular endothelial
growth factor (VEGF) (B), peroxisome proliferator-activated receptor-gamma coactivator 1α
(PGC 1α) (C), and cytochrome c oxidase subunit IV (COX IV) (D; Robust ANOVA),
representative western blotting bands (E). AU: arbitrary unit, BL: baseline, 4w: 4 weeks, 12w: 12
weeks, TRAD: traditional moderate-intensity continuous exercise program, STAIR: stair climbing
based high-intensity interval exercise program, white bars represent TRAD, grey bars represent
STAIR. Data are expressed as means and 95% CI. †p<0.05, significantly different from BL.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Supplemental Digital Content
Supplemental Digital Content 1. Table 1 that illustrate the exercise protocol values following 12
weeks of exercise training. doc.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Figure 1
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Figure 2
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Figure 3
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Figure 4
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Figure 5
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Table 1. Baseline characteristics of the participants.
Variables
Healthy
Controls (n=9)
CAD (n=9)
CAD (n=16)
TRAD (n=7)
STAIR (n=9)
Sex (M/F)
(9/0)
(9/0)
(7/0)
(8/1)
Age (years)
66±4
64±5
61 ± 10
62 ± 6
Height (cm)
175±6
173±5
174 ± 3
175 ± 6
Body mass (Kg)
91±14
90±12
97 ± 20
90 ± 11
BMI (kg/m2)
30±4
30±4
30.2 ± 3.7
29.8 ± 3.3
VO2peak (L/kg/min)
21.7±3.9
23.2±2.5
21.4±4.5
Clinical
STEMI n (%)
-
3 (33.3)
1 (14.3)
2 (22.2)
NSTEMI n (%)
-
4 (44.4)
4 (57.1)
5 (55.6)
Angina n (%)
-
1 (11.1)
1 (14.3)
2 (22.2)
PCI n (%)
-
6 (66.7)
4 (57.1)
7 (77.8)
CABG n (%)
-
3 (33.3)
3 (42.9)
2 (22.2)
Time since event (weeks)
-
9±6
8±4
9±5
Medications
Beta-blockers n (%)
-
8
6 (85.7)
9 (100)
ACE inhibitors n (%)
-
6
6 (85.7)
6 (66.6)
ASA n (%)
-
9
7 (100)
9 (100)
Lipid lowering n (%)
-
9
7 (100)
9 (100)
Metformin n (%)
-
2
1 (14.3)
1 (11.1)
CVD risk factors
T2DM n (%)
-
3 (33.3)
2 (28.6)
1 (11.1)
Hypertension n (%)
-
6 (66.6)
6 (85.7)
6 (66.7)
Dyslipidemia n (%)
-
6 (66.6)
6 (85.7)
6 (66.7)
Blood markers
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Fasted glucose (mM/L)
5.6±1.0
5.4±1.0
5.8±1.00
Fasted insulin (mIU/L)
10.1±6.7
7.3±2.3
12.8±6.8
HDL (mM/L)
1.0±0.3
1.1±0.4
1.0±0.4
LDL (mM/L)
1.3±0.4
1.3±0.4
1.4±0.4
Triglycerides (mM/L)
1.0±0.4
0.8±0.2
1.1±0.4
Cholesterol (mM/L)
2.7±0.6
2.7±0.8
2.9±0.7
Data are expressed as means±SD. BMI: body mass index, STEMI: ST-elevation myocardial
infarction, NSTEMI: non-ST-elevation myocardial infarction, PCI: percutaneous intervention,
CABG: coronary artery bypass graft, ACE: angiotensin-converting enzyme, ASA: acetylsalicylic
acid, T2DM: type 2 diabetes mellitus, HDL: high-density lipoprotein, LDL: low-density
lipoprotein, CAD: coronary artery disease. TRAD: traditional moderate-intensity continuous
exercise program, STAIR: stair climbing based high-intensity exercise program.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED
Supplemental Digital Content
Supplemental Digital Content 1. Table 1 that illustrate the exercise protocol values following 12
weeks of exercise training. doc.
Table 1. Exercise protocol values following 12 weeks of exercise training.
TRAD (n=7)
STAIR (n=9)
p
HRpeak (bpm)
112±14
129±11*
0.008
%HRpeak
89±5
101±1*
0.028
Average of total exercise time
at prescribed intensity (min)
33.3±8.1
5.2±2.2*
<0.001
Data are expressed as means±SD. HR: heart rate, TRAD: traditional moderate-intensity
continuous exercise program, STAIR: stair climbing based high-intensity interval exercise
program. * p<0.05 significantly different from TRAD.
Copyright © 2020 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
ACCEPTED